Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice

Chenglei Li1, Ryan C Burdick1, Rokeya Siddiqui1

  • 1Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.

Summary

Lenacapavir stabilizes the HIV-1 capsid lattice while disrupting core integrity, unlike PF74 which affects both. This difference impacts nuclear import inhibition mechanisms for HIV-1 replication.